Update on anti-tumor necrosis factor agents in Crohn disease, Gastroenterol Clin North, vol.87 ,
, Am, vol.43, issue.3, pp.457-78, 2014.
Rapid subcutaneous desensitization for the management of local 89 and systemic hypersensitivity reactions to etanercept and adalimumab in 12 patients, J Allergy Clin Immunol, vol.90 ,
, , vol.3, pp.629-661, 2015.
, Fernández Meléndez S, vol.92
Adalimumab desensitization protocol in a patient with a generalized urticarial 93 reaction and angioedema following adalimumab administration, J Investig Allergol Clin Immunol, vol.94, issue.4, pp.273-278, 2014. ,
, , p.96
Successful adalimumab desensitization after generalized urticaria and rhinitis, J Investig, p.97 ,
, Allergol Clin Immunol, vol.19, issue.3, pp.246-253, 2009.
Adalimumab desensitization after anaphylactic reaction ,
, Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol, vol.106, issue.6, pp.547-555, 2011.
Rapid drug desensitization for hypersensitivity reactions to chemotherapy and 101 monoclonal antibodies in the 21st century, J Investig Allergol Clin Immunol, vol.24, issue.2, pp.72-81, 2014. ,
Distinct parameters of the basophil 104 activation test reflect the severity and threshold of allergic reactions to peanut, J Allergy Clin Immunol, vol.135, issue.1, pp.179-86, 2015105-01. ,
Ara h 2 basophil activation 107 test does not predict clinical reactivity to peanut, J Allergy Clin Immunol Pract, 2018. ,
, Basophil Activation Test is a Relevant, vol.109
, Biomarker of the Outcome of Rapid Desensitization in Platinum Compounds-Allergy, J Allergy Clin Immunol, vol.110
, , vol.5, pp.728-764, 2017.